Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Type II Diabetes Mellitus: early-phase trial registry
3 of 8 indexed Type II Diabetes Mellitus trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #2,176 of 28,707 conditions by registered trial count.
8 US clinical trials · 3 currently recruiting · #2,176 of 28,707 conditions by registered trial count
Type II Diabetes Mellitus: 8 US clinical trials tracked, 3 recruiting.
Type II Diabetes Mellitus is the subject of 8 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is Sun Pharmaceutical Industries Limited, running 2 of these trials.
Enrollment posture brief
Registry condition type-ii-diabetes-mellitus
OPEN 3 | RECR 38% | LATE 1 | EARLY 3 | RANK #2176 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Acute-graft-versus-host Disease (38% recruiting · 8 trials)
Type II Diabetes Mellitus lists 3 open slots (38% of 8 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Type II Diabetes Mellitus on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Type II Diabetes Mellitus is recruiting below its size-band peers.
3 of 8 indexed trials (37.5%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Type II Diabetes Mellitus research.
Sun Pharmaceutical Industries Limited accounts for 2 of 8 trials (25%). 7 distinct sponsors appear on at least one study for this condition label.
-
Typical Type II Diabetes Mellitus enrolment sits around 114 participants.
Median target enrolment is 114 among the 8 trials that report a genuine target (sentinel values excluded). 4 of those (50%) plan for fewer than 100 participants.
-
Type II Diabetes Mellitus research is mostly interventional.
8 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
8 total, page 1 of 1
Efficacy and Safety of GL0034 in Overweight or Obese Adults With Type II Diabetes Mellitus
Sun Pharmaceutical Industries Limited
NCT07282743
The GRoceries Aimed at Increasing Nutrition Study
University of Pennsylvania
NCT07167004
Study to Evaluate if Exposure to Drug is Impacted in Participants With Renal Insufficiency
Sun Pharmaceutical Industries Limited
NCT07385547
Safety and Efficacy Study of JTT-130 in Obese Type 2 Diabetic Patients
Akros Pharma
NCT00929539
Intrapartum Glycemic Control With Insulin Infusion Versus Rotating Fluids
Geisinger Clinic
NCT03912363
SGLT2 Inhibition and Stimulation of Endogenous Glucose Production: Protocol 2
The University of Texas Health Science Center at San Antonio
NCT02592421
The Use of a Computer Program to Help Primary Care Providers Treat Patients With Type 2 Diabetes
Walter Reed National Military Medical Center
NCT01648244
Effects of a Spiced Meat Patty on Inflammation in Men With Type 2 Diabetes
University of California, Los Angeles
NCT01076829
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 2 |
| Phase 3 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Type II Diabetes Mellitus records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Type II Diabetes Mellitus trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Type II Diabetes Mellitus page
8 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 Type II Diabetes Mellitus trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Sun Pharmaceutical Industries Limited sponsors the most Type II Diabetes Mellitus trials on record, review their full trial history before evaluating a specific study. See Sun Pharmaceutical Industries Limited's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Type II Diabetes Mellitus condition card totals 8 registered trials; most-linked intervention Insulin infusion protocol; top US site state Florida. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.